The price growth for top drugs covered by Medicare Part D has exceeded inflation, according to a new AARP report. The 25 drugs studied have increased by an average of 98%, or nearly doubled, since ...
It is the first drug from a new class that doesn't directly block dopamine to improve symptoms. Feeling out of the loop? We'll catch you up on the Chicago ... CNBC's Disruptor 50 list last year ...
CHICAGO – Four Chicago residents have been arrested on federal drug and firearm charges as result of a drug trafficking investigation. The U.S. Attorney’s Office for the Northern District of ...
January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...
Two commercial leaders at Chicago-based Meitheal sat down with Crain's to discuss the way the company's strategy of U.S. commercialization of two branded drugs, Xenleta and Contepo, along with ...
A Hammond man faces 25 years for killing a 15-year-old selling marijuana in a botched $140 drug deal. Christopher Wells, 22, admitted Wednesday in a plea deal to voluntary manslaughter ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...
WASHINGTON — List prices for the 25 top Medicare Part D drugs not currently selected for Medicare drug price negotiation have increased by an average of 98 percent—or nearly doubled—since ...
The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations have increased by an average 98% since they hit the market, according to ...
Despite recent developments in the fight to corral high U.S. drug prices, the trend toward consistently rising costs—which has held true for years—is likely to persist for the foreseeable future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback